Skip to main content
Close
Publicación

Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy.

Ver todas las publicaciones
Not available in
This is not available in . You can go to the translated versions in these languages: